---
$id: https://graph.org.ai/products/commodity/51142564
$type: Product
source: UNSPSC
code: "51142564"
title: "Pramipexole dihydrochloride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pramipexole dihydrochloride

**UNSPSC Code**: 51142564
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C10H17N3S.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3D867NP06J, chemically known as 2,6-benzothiazolediamine, 4,5,6,7-tetrahydro-n6-propyl-, dihydrochloride, (s)- but more generally known as pramipexole dihydrochloride, which bears US NIH Compound Identifier 119569. European Medicines Agency schedules Pramipexole dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04004MIG. Most nations, for tariff and trade purposes, schedule pramipexole dihydrochloride under HS 29341000 and SITC 51579. As of Q4 2014, PRAMIPEXOLE DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Pramipexole dihydrochloride bears US NLM identifiers UMLS ID C0721754 and NCI Concept Code C29374. SMILES: CCCN[C@H]1CCC2C(SC(N2)N)C1.O.CL.CL.

